Viva Biotech Holdings (VBIZF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.76 Billion CNY | -12.84% |
| 2022 | 4.31 Billion CNY | 4.47% |
| 2021 | 4.13 Billion CNY | -6.05% |
| 2020 | 4.39 Billion CNY | 3522.38% |
| 2019 | 121.39 Million CNY | -56.32% |
| 2018 | 277.89 Million CNY | 459.82% |
| 2017 | 49.64 Million CNY | 96.06% |
| 2016 | 25.31 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 3.37 Billion CNY | 0.0% |
| 2024 Q1 | 3.37 Billion CNY | -10.2% |
| 2023 FY | 3.76 Billion CNY | -12.84% |
| 2023 Q1 | 4.5 Billion CNY | 4.43% |
| 2023 Q4 | 3.76 Billion CNY | 0.0% |
| 2023 Q3 | 3.76 Billion CNY | -16.53% |
| 2023 Q2 | 4.5 Billion CNY | 0.0% |
| 2022 Q4 | 4.31 Billion CNY | 0.0% |
| 2022 FY | 4.31 Billion CNY | 4.47% |
| 2022 Q3 | 4.31 Billion CNY | 2.23% |
| 2022 Q2 | 4.22 Billion CNY | 0.0% |
| 2022 Q1 | 4.22 Billion CNY | 2.19% |
| 2021 Q1 | 4.11 Billion CNY | -6.5% |
| 2021 Q3 | 4.13 Billion CNY | 0.49% |
| 2021 Q4 | 4.13 Billion CNY | 0.0% |
| 2021 FY | 4.13 Billion CNY | -6.05% |
| 2021 Q2 | 4.11 Billion CNY | 0.0% |
| 2020 Q3 | 4.39 Billion CNY | 214.25% |
| 2020 FY | 4.39 Billion CNY | 3522.38% |
| 2020 Q1 | 1.39 Billion CNY | 1052.72% |
| 2020 Q4 | 4.39 Billion CNY | 0.0% |
| 2020 Q2 | 1.39 Billion CNY | 0.0% |
| 2019 Q3 | 121.39 Million CNY | 2.45% |
| 2019 Q1 | 118.48 Million CNY | -57.36% |
| 2019 FY | 121.39 Million CNY | -56.32% |
| 2019 Q4 | 121.39 Million CNY | 0.0% |
| 2019 Q2 | 118.48 Million CNY | 0.0% |
| 2018 FY | 277.89 Million CNY | 459.82% |
| 2018 Q3 | 277.89 Million CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 Q4 | 277.89 Million CNY | 0.0% |
| 2017 FY | 49.64 Million CNY | 96.06% |
| 2016 FY | 25.31 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -13713310.856% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | -6274.753% |
| Neon Bloom, Inc. | 1.22 Million USD | -306698.248% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -465036.982% |
| Qrons Inc. | 1.48 Million USD | -252601.495% |
| Regen BioPharma, Inc. | 5.45 Million USD | -68831.196% |
| Evofem Biosciences, Inc. | 72.47 Million USD | -5091.042% |
| BioStem Technologies, Inc. | 15.9 Million USD | -23553.435% |
| Skye Bioscience, Inc. | 14.07 Million USD | -26633.505% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -8416760.569% |
| Rebus Holdings, Inc. | 5.24 Million USD | -71666.501% |
| CSL Limited | 18.62 Billion USD | 79.797% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | -4921.356% |
| Capstone Therapeutics Corp. | 50.26 Million USD | -7384.482% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -1870462.263% |
| Adynxx, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 9.46 Million USD | -39642.567% |
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | -6957.499% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | -39161.024% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -892282.724% |
| SQZ Biotechnologies Company | 50.03 Million USD | -7418.136% |
| Intellipharmaceutics International Inc. | 12 Million USD | -31227.113% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -97578.157% |
| Mesoblast Limited | 188.44 Million USD | -1896.342% |
| Marizyme, Inc. | 26.67 Million USD | -14002.717% |
| Genus plc | 485 Million USD | -675.67% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -64288.91% |
| Pharming Group N.V. | 244.07 Million USD | -1441.342% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -187052.075% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -149403.562% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -98900.0% |
| ContraFect Corporation | 32.53 Million USD | -11464.354% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -189774.568% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -98184.9% |
| IMV Inc. | 37.93 Million USD | -9817.54% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | -31840.378% |
| MultiCell Technologies, Inc. | 1617.67 USD | -232556601.923% |
| ONE Bio Corp. | 27.49 Million USD | -13582.085% |
| Accustem Sciences Inc. | 1.07 Million USD | -348478.952% |
| RVL Pharmaceuticals plc | 77.41 Million USD | -4759.398% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 2.11 Million USD | -177766.538% |
| Q BioMed Inc. | 8.13 Million USD | -46156.341% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | -4436.082% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -73004.827% |
| Biomind Labs Inc. | 1.49 Million USD | -250932.289% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | -3068.741% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | -41504.947% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | -20341.858% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -262268.528% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -2647424.543% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -65373.672% |
| GB Sciences, Inc. | 5.41 Million USD | -69340.894% |
| Alpha Cognition Inc. | 7.16 Million USD | -52406.89% |
| HST Global, Inc. | 593.59 Thousand USD | -633667.581% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -298662.779% |
| Halberd Corporation | 728.71 Thousand USD | -516148.376% |
| Enzolytics Inc. | 365.26 Million USD | -929.926% |
| Agentix Corp. | 2.51 Million USD | -149747.345% |
| Resverlogix Corp. | 67.39 Million USD | -5481.934% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -448434.216% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 444.95 Million USD | -745.486% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -219386.581% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | -15102.44% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | -31505.209% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -102542.065% |
| AVAX Technologies, Inc. | 3.99 Million USD | -94097.301% |
| Zenith Capital Corp. | 27.56 Thousand USD | -13645661.544% |
| Genscript Biotech Corporation | 1.32 Billion USD | -183.738% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -1576240.644% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -100641.61% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -552457.598% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -138635.179% |
| Kadimastem Ltd | 3.5 Million USD | -107236.455% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -5620781.83% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -809456.293% |
| LadRx Corporation | 2.2 Million USD | -170858.97% |
| Cell Source, Inc. | 15.8 Million USD | -23700.013% |
| Regen BioPharma, Inc. | 5.45 Million USD | -68831.196% |
| NovAccess Global Inc. | 7.86 Million USD | -47758.138% |
| Affymax, Inc. | 8.87 Million USD | -42307.846% |
| Itoco Inc. | 1.65 Million USD | -227465.419% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -183272.206% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -62092.098% |
| Mobile Lads Corp. | 1.31 Million USD | -286311.008% |
| CytoDyn Inc. | 127.89 Million USD | -2841.498% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -9000115.316% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -240072.066% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | -33959.77% |
| SYBLEU INC | 681.41 Thousand USD | -551988.088% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -61552.877% |
| International Stem Cell Corporation | 5.27 Million USD | -71190.506% |
| Bioxytran, Inc. | 3.24 Million USD | -115671.657% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -601041.882% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -81379.276% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | -9076.505% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | -16796.474% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -185642.28% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -68574.699% |
| Neutra Corp. | 973.52 Thousand USD | -386329.166% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -12865.707% |
| PureTech Health plc | 125.58 Million USD | -2895.628% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -100029.753% |
| IXICO plc | 1.9 Million USD | -197869.575% |
| IntelGenx Technologies Corp. | 20.52 Million USD | -18225.296% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -3540.974% |
| CSL Limited | 18.62 Billion USD | 79.797% |
| Cellectis S.A. | 249.36 Million USD | -1408.605% |